Articles

This section includes the latest articles from American Pharmaceutical Review magazine. Articles featured in this section cover a wide range of topics of critical interest to the biopharm and pharmaceutical industries. From R&D strategies, meeting regulatory requirements, and new insights into manufacturing efficiencies, the articles featured here will give you the insight and knowledge needed to bring the latest medicines to market.

Filter

Hide Filter

  • Liquid Chromatography – Mass Spectrometry Roundtable

    Thursday, March 16, 2017
    What are some “must-have” features that pharma companies are looking for when evaluating Liquid Chromatography and Mass Spectrometry equipment? read more

  • Disposable Technology Roundtable

    Thursday, March 16, 2017
    Over the past 10 years, we have seen a steady increase in the adoption of single-use technologies (SUT) by the biopharmaceutical industry. The widespread utilization of single-use filter cartridges and capsules paved ... read more

  • BPOG Five-Year Vision for Single-Use Technologies

    Thursday, March 16, 2017
    Single-use technologies (SUT) for biomanufacturing, otherwise known as disposable technologies, have the potential to transform the industry through more cost effective solutions and solve crucial manufacturing and ... read more

  • The Data Generation

    Wednesday, March 15, 2017
    The pharmaceutical market landscape remains tremendously dynamic in 2017. Outsourcing practices for drug discovery, product and process development, clinical trials and manufacturing continue to evolve as well. Data —... read more

  • Keys to Cultural Integration

    Wednesday, March 15, 2017
    WHY IS CULTURAL INTEGRATION FOLLOWING A MERGER SO IMPORTANT TO THE SUCCESS OF THE NEWLY FORMED ENTITY? read more

  • An OEE Approach to Solid Dose Equipment Purchasing and Implementation

    Wednesday, March 15, 2017
    Acquiring pharmaceutical processing equipment and successfully integrating it into operations is not as straightforward as it may seem. Whether used or new, everything is up for consideration and evaluation: ... read more

  • Expanding the Commercial Options for Preparation of Amorphous Solid Dispersions

    Wednesday, March 15, 2017
    Solubility in physiological fluids is a prerequisite for high bioavailability of drug substances. For many APIs that exhibit poor water solubility, bioavailability can be enhanced by preparing the product in an ... read more

  • Experience and Expertise Facilitate Controlled Substance Manufacturing

    Wednesday, March 15, 2017
    Requirements for the manufacture of controlled substances impact all aspects of drug development, manufacturing and distribution. CDMOs that have an in-depth understanding of the regulations, long-standing positive ... read more

  • Investing for Successful Advancement of Viral Vector Manufacturing

    Wednesday, March 15, 2017
    Gene therapies are designed to treat diseases by modifying genetic information, including correcting genes that function improperly or adding normal copies of defective genes. They have the potential to address and ... read more

  • Enhancing Responsiveness with Embedded Flexibility

    Wednesday, March 15, 2017
    Responsiveness has always been a key expectation for contract manufacturers providing services to the pharmaceutical industry. Today, however, with increased competition, the growing importance of evidence-based ... read more

  • Industry Benchmark

    Wednesday, March 15, 2017
    At the heart of That’s Nice is the Nice Insight division, which provides data and analysis from proprietary annual surveys as well as custom primary and secondary research of many kinds. Nice Insight is tasked every ... read more

  • Changes In the Wind for the CDMO Market

    Wednesday, March 15, 2017
    The global pharmaceutical market continues to grow at a healthy rate. According to research firm Evaluate Pharma, the global drug market will expand at a compound annual growth rate (CAGR) of 6.3% from 2016 to 2022, ... read more

  • Achieving Security of Supply with Effective Particle Engineering

    Wednesday, March 15, 2017
    Targeted particle engineering for solid dosage drug formulations has become an imperative given the challenging compounds in the pharmaceutical pipeline, the growing interest in inhaled delivery, and the move to ... read more

  • Spending on Contract Research Services Slowing Down

    Wednesday, March 15, 2017
    The 2017 Nice Insight Clinical Research Organization (CRO) Outsourcing Survey1 includes input from 608 outsourcing-facing pharmaceutical and biotechnology executives. The majority of the respondents are key decision ... read more

  • Continuous Manufacturing: To Be Continued…

    Wednesday, March 15, 2017
    I don’t know why it’s not more widely used… this is the future,” said Janet Woodcock, director of the Center for Drug Evaluation & Research at the U.S. Food & Drug Administration (FDA), when asked to explain the ... read more
Page